Journal of Cancer Therapy
Vol.8 No.5(2017), Paper ID 76640, 12
pages
DOI:10.4236/jct.2017.85043
Tumor-Associated Autoantibodies: Re-Optimization of EarlyCDT-Lung Diagnostic Performance and Its Application to Indeterminate Pulmonary Nodules
Graham F. Healey, Isabel K. Macdonald, Chris Reynolds, Jared Allen, Andrea Murray
Oncimmune Holdings plc, Nottingham City Hospital, Nottingham, UK
Oncimmune Holdings plc, Nottingham City Hospital, Nottingham, UK
Oncimmune Holdings plc, Nottingham City Hospital, Nottingham, UK
Oncimmune Holdings plc, Nottingham City Hospital, Nottingham, UK
Oncimmune Holdings plc, Nottingham City Hospital, Nottingham, UK
Copyright © 2017 Graham F. Healey, Isabel K. Macdonald, Chris Reynolds, Jared Allen, Andrea Murray et al. This is
an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any
medium, provided the original work is properly cited.
How to Cite this Article
Healey, G. , Macdonald, I. , Reynolds, C. , Allen, J. and Murray, A. (2017) Tumor-Associated Autoantibodies: Re-Optimization of EarlyCDT-Lung Diagnostic Performance and Its Application to Indeterminate Pulmonary Nodules.
Journal of Cancer Therapy,
8, 506-517. doi:
10.4236/jct.2017.85043.